nafamostat has been researched along with Angioma, Cavernous in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Angioma, Cavernous: A tumor-like mass with large vascular space that is filled with blood or lymph.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, H | 1 |
| Nimura, Y | 1 |
| Kamiya, J | 1 |
| Kondo, S | 1 |
| Nagino, M | 1 |
| Kanai, M | 1 |
| Miyachi, M | 1 |
1 review available for nafamostat and Angioma, Cavernous
| Article | Year |
|---|---|
Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy.
Topics: Adult; Anticoagulants; Benzamidines; Combined Modality Therapy; Disseminated Intravascular Coagulati | 1997 |